首页> 外文期刊>Amyotrophic lateral sclerosis and other motor neuron disorders: Official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases >A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China
【24h】

A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China

机译:中国罕见的引起家族性肌萎缩性侧索硬化症的Cu / Zn超氧化物歧化酶突变,发病年龄不同,外pen不完全

获取原文
获取原文并翻译 | 示例
       

摘要

More than 100 mutations in the Cu/Zn superoxide dismutase ( SOD) gene have been found, accounting for about 20% of familial ALS (FALS). However, few have been identified in Chinese patients with FALS. We present a five-generation Chinese family with FALS with a rare mutation in exon 4 of the Cu/Zn SOD gene codon position 105, converting serine to leucine. Forty-seven family members including the proband were examined clinically; two affected persons had EMG and nerve conduction studies. Genomic DNA was extracted from peripheral blood leukocytes of the family members after informed consent. All five exons of the Cu/Zn SOD gene were amplified by polymerase chain reaction (PCR) and DNA sequencing was performed on purified products. Exon 4 of the Cu/Zn SOD gene was amplified from genomic DNA isolated from not only the family members but also from 50 unrelated healthy Chinese control subjects. A rare S105L mutation, which is heterozygous with C by T at position 1125 of the coding sequence in exon 4 of the Cu/Zn SOD gene, was found in the proband and her affected elder brother. The clinical phenotype within the FALS patients in this family is relatively variable. The age at onset ranged from 32 to 65 years, with initial symptoms in either the upper or lower extremities in different family members. Two subjects aged 72 and 60 years remained asymptomatic until their death from other causes, although their offspring carrying the same mutation have already developed clinical evidence of the disease. The S105L mutation was identified in another seven asymptomatic family members, aged 7 to 59 years. It is concluded that the S105L mutation in exon 4 of the Cu/Zn SOD gene is pathogenic. The phenotype is characterized by relatively variable clinical symptoms, with incomplete penetrance.
机译:已发现Cu / Zn超氧化物歧化酶(SOD)基因中的100多个突变,约占家族性ALS(FALS)的20%。但是,在中国的FALS患者中几乎没有发现。我们介绍了一个具有FALS的五代中国家庭,其具有在Cu / Zn SOD基因密码子位置105的外显子4中罕见的突变,将丝氨酸转化为亮氨酸。临床检查了包括先证者在内的47个家庭成员;两名受影响的人进行了肌电图和神经传导研究。在知情同意后,从家庭成员的外周血白细胞中提取基因组DNA。通过聚合酶链反应(PCR)扩增了Cu / Zn SOD基因的所有五个外显子,并对纯化的产物进行了DNA测序。 Cu / Zn SOD基因的第4外显子不仅从家族成员中分离出的基因组DNA,而且从50名不相关的中国健康对照者中分离得到。在先证者及其患病的哥哥中发现了一个罕见的S105L突变,在Cu / Zn SOD基因第4外显子的编码序列的1125位置与C杂合为T。该家族的FALS患者的临床表型相对可变。发病年龄在32至65岁之间,不同家庭成员的上肢或下肢都有初始症状。两名年龄分别为72岁和60岁的受试者一直无症状,直到因其他原因死亡,尽管他们的后代携带相同的突变已经开发出该疾病的临床证据。 S105L突变在另外7名无症状家庭成员中发现,年龄在7至59岁之间。结论是,Cu / Zn SOD基因第4外显子的S105L突变是致病的。该表型的特点是临床症状相对多变,外显率不完全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号